戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 1072501作成日:2026年10月25日

1-((4-Chlorophenyl)methyl)piperidin-4-amine → N-(2-{(2R)-3-[1-(4-Chloro-benzyl)-piperidin-4-ylamino]-2-hydroxy-2-methylpropoxy}-phenyl)-acetamide

https://huagongshe.com/reaction/1072501

反応式

関与物質

役割名称HCID仕込み量
反応物1-((4-Chlorophenyl)methyl)piperidin-4-amineHCID 7130833—
反応物N-(2-{[(2R)-2-Methyloxiranyl]methoxy}phenyl)acetamideHCID 86597619—
溶媒EthanolHCID 702—
溶媒WaterHCID 962—
生成物N-(2-{(2R)-3-[1-(4-Chloro-benzyl)-piperidin-4-ylamino]-2-hydroxy-2-methylpropoxy}-phenyl)-acetamideHCID 10182107105.6%

反応手順

1-(4-chlorobenzyl)-4-piperidinamine (62 mg, 0.276 mmol) and N-(2-{[(2R)-2-methyloxiranyl]methoxy}phenyl)acetamide (61 mg, 0.276 mmol) in ethanol (1.5 ml) was stirred in a sealed vial at 80° C. for 4 hours. The reaction mixture was diluted with water and purified by reversed phase HPLC to give 130 mg (70%) of the title compound as a ditrifluoroacetate after lyophilisation. The optical purity was determined to 86% ee, by chiral HPLC on a Chiralpak AD-column.

情報源と証拠

DOI10.6084/m9.figshare.5104873.v1
特許番号US06911458B2
出典データセットuspto-grants-2005_06
ORD IDord-f7a4eb3793b6433d83cc46d986c14cdd
出典メモuspto-grants-2005_06